• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过预防实验性攻毒来确定活的鸡滑液囊支原体疫苗Vaxsafe MS(MS-H株)的有效剂量。

Determination of the effective dose of the live Mycoplasma synoviae vaccine, Vaxsafe MS (strain MS-H) by protection against experimental challenge.

作者信息

Jones Jillian F, Whithear Kevin G, Scott Peter C, Noormohammadi Amir H

机构信息

School of Veterinary Science, The University of Melbourne, Werribee, Victoria, 3052, Australia.

出版信息

Avian Dis. 2006 Mar;50(1):88-91. doi: 10.1637/7429-083005R.1.

DOI:10.1637/7429-083005R.1
PMID:16617988
Abstract

The minimum effective dose of the Mycoplasma synoviae-H (MS-H) vaccine was determined through protection against experimental challenge. Chickens were vaccinated by eyedrop with the following doses of a vaccine: 1.2 x 10(5), 2.4 x 10(5) 4.8 x 10(5), 9.6 x 10(5), 1.92 X 10(6), and 3.84 X 10(6) color change units (CCU), then challenged 6 wk after vaccination. Rapid serum agglutination results indicated that 100% of birds receiving an MS-H dose of > or = 4.8 x 10(5) CCU had antibodies to MS and enzyme-linked immunosorbent assay results showed that 60% of birds receiving a dose of 4.8 x 10(5) or 9.6 x 10(5) CCU and 100% of birds receiving a dose of 1.92 x 10(6) or 3.84 x 10(6) had antibodies to MS. At postmortem after challenge, the following parameters were significantly lower in birds vaccinated with an MS-H dose of > or = 4.8 x 10(5) CCU: air sac (AS) lesion severity; incidence of AS lesions; mucosal thicknesses in the upper trachea, middle trachea, and lower trachea (LT); and MS colonization of the LT and AS. It was concluded that an MS-H dose of 4.8 x 10(5) CCU was sufficient to elicit an antibody response in birds, prevent MS colonization in the LT and AS, and protect against AS lesions caused by an experimental MS and infectious bronchitis virus challenge.

摘要

通过对实验性攻毒的保护作用来确定滑膜支原体-H(MS-H)疫苗的最小有效剂量。给鸡滴眼接种以下剂量的疫苗:1.2×10⁵、2.4×10⁵、4.8×10⁵、9.6×10⁵、1.92×10⁶和3.84×10⁶个颜色变化单位(CCU),然后在接种后6周进行攻毒。快速血清凝集结果表明,接受MS-H剂量≥4.8×10⁵ CCU的鸡中100%具有抗MS抗体,酶联免疫吸附测定结果显示,接受4.8×10⁵或9.6×10⁵ CCU剂量的鸡中60%以及接受1.92×10⁶或3.84×10⁶剂量的鸡中100%具有抗MS抗体。攻毒后剖检时,接受MS-H剂量≥4.8×10⁵ CCU的鸡在以下参数方面显著较低:气囊(AS)病变严重程度;AS病变发生率;上呼吸道、中呼吸道和下呼吸道(LT)的黏膜厚度;以及LT和AS中的MS定植。得出的结论是,4.8×10⁵ CCU的MS-H剂量足以在鸡中引发抗体反应,防止MS在LT和AS中定植,并预防由实验性MS和传染性支气管炎病毒攻毒引起的AS病变。

相似文献

1
Determination of the effective dose of the live Mycoplasma synoviae vaccine, Vaxsafe MS (strain MS-H) by protection against experimental challenge.通过预防实验性攻毒来确定活的鸡滑液囊支原体疫苗Vaxsafe MS(MS-H株)的有效剂量。
Avian Dis. 2006 Mar;50(1):88-91. doi: 10.1637/7429-083005R.1.
2
Duration of immunity with Mycoplasma synoviae: comparison of the live attenuated vaccine MS-H (Vaxsafe MS) with its wild-type parent strain, 86079/7NS.鸡滑液支原体的免疫持续时间:减毒活疫苗MS-H(Vaxsafe MS)与其野生型亲本菌株86079/7NS的比较。
Avian Dis. 2006 Jun;50(2):228-31. doi: 10.1637/7465-103005R.1.
3
Onset of immunity with Mycoplasma synoviae: comparison of the live attenuated vaccine MS-H (Vaxsafe MS) with its wild-type parent strain (86079/7NS).鸡滑液支原体免疫的起始:减毒活疫苗MS-H(Vaxsafe MS)与其野生型亲本菌株(86079/7NS)的比较。
Avian Dis. 2006 Mar;50(1):82-7. doi: 10.1637/7428-083005R.1.
4
Safety and efficacy of the Mycoplasma synoviae MS-H vaccine in turkeys.鸡滑液囊支原体MS-H疫苗在火鸡中的安全性和有效性。
Avian Dis. 2007 Jun;51(2):550-4. doi: 10.1637/0005-2086(2007)51[550:SAEOTM]2.0.CO;2.
5
Quantification of the horizontal transmission of Mycoplasma synoviae in non-vaccinated and MS-H-vaccinated layers.鸡滑液支原体在未接种疫苗和接种MS-H疫苗蛋鸡中的水平传播定量研究。
Avian Pathol. 2017 Aug;46(4):346-358. doi: 10.1080/03079457.2017.1282602. Epub 2017 Mar 24.
6
Improved detection of antibodies to Mycoplasma synoviae vaccine MS-H using an autologous recombinant MSPB enzyme-linked immunosorbent assay.使用自体重组MSPB酶联免疫吸附测定法改进对滑膜支原体疫苗MS-H抗体的检测。
Avian Pathol. 2002 Dec;31(6):611-7. doi: 10.1080/0307945021000024553.
7
Poor systemic antibody response after vaccination of commercial broiler breeders with Mycoplasma gallisepticum vaccine ts-11 not associated with susceptibility to challenge.用鸡毒支原体疫苗ts-11对商品肉种鸡进行接种后,全身抗体反应较差,但这与攻毒易感性无关。
Avian Dis. 2002 Jul-Sep;46(3):623-8. doi: 10.1637/0005-2086(2002)046[0623:PSARAV]2.0.CO;2.
8
Effect of a live Mycoplasma synoviae vaccine on the production of eggshell apex abnormalities induced by a M. synoviae infection preceded by an infection with infectious bronchitis virus D1466.感染传染性支气管炎病毒 D1466 后再感染滑膜支原体对蛋壳顶点异常产生的影响与滑膜支原体活疫苗的作用。
Avian Pathol. 2009 Oct;38(5):333-40. doi: 10.1080/03079450903183652.
9
Safety of a temperature-sensitive clone of Mycoplasma synoviae as a live vaccine.滑膜支原体温度敏感株作为活疫苗的安全性
Avian Dis. 1998 Oct-Dec;42(4):677-81.
10
Efficacy of a temperature-sensitive Mycoplasma synoviae live vaccine.一种温度敏感型鸡滑液囊支原体活疫苗的效力
Avian Dis. 1998 Oct-Dec;42(4):671-6.

引用本文的文献

1
Recombinant adenovirus expressing pdhβ-pdhD fusion protein produces robust immune responses and partial protection against Mycoplasma Synoviae challenge in chickens.表达pdhβ-pdhD融合蛋白的重组腺病毒在鸡中产生强大的免疫反应并对鸡滑液囊支原体攻击提供部分保护。
Poult Sci. 2025 May 1;104(7):105185. doi: 10.1016/j.psj.2025.105185.
2
Target antigen screening and development of a multi-component subunit vaccine against in chickens.针对鸡的 靶抗原筛选和多组分亚单位疫苗的开发。
Front Cell Infect Microbiol. 2024 Oct 23;14:1458865. doi: 10.3389/fcimb.2024.1458865. eCollection 2024.
3
Development of a Serum-Free Medium To Aid Large-Scale Production of -Based Therapies.
开发一种无血清培养基以辅助基于 的疗法的大规模生产。
Microbiol Spectr. 2023 Jun 15;11(3):e0485922. doi: 10.1128/spectrum.04859-22. Epub 2023 Apr 25.